A PYMNTS Company

India: Apollo Hospitals’ pharma business deal approved by CCI

By  |  September 23, 2019

The Competition Commission of India (CCI) on Monday, September 23, stated it has approved the restructuring of Apollo Hospitals Enterprise’s pharmacy business and its subsequent acquisition by certain investors.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Apollo Hospitals in November 2018 had announced that it would divest its front-end pharmacy business to Apollo Pharmacy for a lump sum cash consideration of 5.28 billion rupees (US$74.5 million) crore as part of a restructuring exercise.

    The CCI in a tweet on Monday stated it “approves restructuring of pharmacy business of Apollo Hospitals Enterprise Limited and its subsequent acquisition by Enam Securities Private Limited, Jhelum Investment Fund I, and Hemendra Kothari.”

    Under the new structure, Apollo Hospitals will be the exclusive supplier for Apollo Pharmacy under a long-term supplier agreement. 

    Full Content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.